Forty Seven, a GV-backed immuno-oncology spinout from Stanford University, has filed for a $115m initial public offering on Nasdaq just eight months after closing a $75m series B.

Forty Seven, a GV-backed immuno-oncology spinout from Stanford University, has filed for a $115m initial public offering on Nasdaq just eight months after closing a $75m series B.

United, Mitsui, Itochu and GMO-backed e-commerce platform Mercari has priced its initial public offering at the top of its range and will raise up to $1.19bn in Tokyo this month.

Jon McCarry has taken a role at UNT's Murphy Center for Entrepreneurship and Innovation as the hub looks to strengthen its presence beyond the university.

Johnson & Johnson, Intermountain Healthcare and Nvidia have backed a $30m series C round for Zebra Medical Vision.

The customer engagement software developer has raised $60m from investors including GV, the early-stage investment arm of Alphabet that previously supported a $32m series A.

Kunlun-backed Nashwork has attracted $78m in a series B+ round backed by Sino-Ocean Group.